Jazz Pharmaceuticals plc — Director's Dealing 2014

Nov 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-11-06

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-06	Ordinary Shares	M	5000	$46.83	Acquired	26713	Direct
2014-11-06	Ordinary Shares	M	2000	$59.13	Acquired	28713	Direct
2014-11-06	Ordinary Shares	S	7000	$170.1196	Disposed	21713	Direct
2014-11-06	Ordinary Shares	S	596	$170.00	Disposed	21117	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-06	Nonstatutory Stock Option (right to buy)	$46.83	M	5000	Disposed	2022-08-08	Ordinary Shares (5000)	Direct
2014-11-06	Nonstatutory Stock Option (right to buy)	$59.13	M	2000	Disposed	2023-03-04	Ordinary Shares (2000)	Direct

Footnotes

F1: As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 625 shares and will vest with respect to 625 shares on December 9, 2014, with respect to 6,587 shares in equal monthly installments from January 9, 2015 to December 9, 2015 and with respect to 2,865 shares in equal monthly installments from January 9, 2016 to August 9, 2016.

F2: As of the date of this report, the remaining ordinary shares subject to this option will vest with respect to 250 shares on December 5, 2014 and with respect to 6,000 shares in equal monthly installments from January 5, 2015 to December 5, 2016.